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1. !ntroduction 
The rudimentary locus (I; l-54.5) in Drosophila 
melanogaster [l] is involved in the genetic regulation 
of pyrimidine biosynthesis [2--S]. Based on genetic 
and biochemical data it is assumed [3,4,6] that this 
locus comprises the structural genes for the first two 
enzymes of the pyrimidine pathway, i.e. carbamoyl 
phosphate synthetase (CPS) and aspartate carbamoyl- 
transferase (ACT), and that these enzymes form a 
bifunctional complex [4,7] like in some other 
eukaryotes [ 81. Recent experiments [ 91 indicate 
that the r locus also determines the activity of the 
third enzyme in the pathway, i.e. dihydroorotase 
(DHO), with the possibility that this enzyme is 
included in the postulated complex, as it is known to 
be in mammalian systems [8, lo] . 
As part of an effort to further clarify the function 
of the r locus, the present paper reports a partial 
purification and characterization of ACT from wild 
type D. melanogaster and from the rudimentary 
strain r3gk. 
* Present address: Institute of Genetics, University of 
Copenhagen, 0. Farimagsgade 2A, DK-135 3 Copenhagen K, 
Denmark. 
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2. Materials and methods 
2.1. Drosophila cultures 
The Drosophila strains used were Oregon-R wild 
type and the rudimentary strain r3gk, cultured at 
25’C on standard yeast-sucrose media [2] . In case 
of the mutant strain RNA was added to the medium 
to a final concentration of 1%. 
2.2. Preparation of extract 
2-day old larvae were harvested and homogenized 
as described earlier [3], except that the homogeni- 
zation buffer used in the present investigation was 
as follows: 0.1 M potassium phosphate pH 8.0-8.3, 
10% (w/v) in glycerol, and 1 mM in phenylthiourea 
(PTU’), mercaptoethanol, and EDTA. 
The enzyme solution obtained after filtration of 
the centrifuged homogenate is referred to as the 
crude extract. 
2.3. Enzyme assay and protein determination 
Aspartate carbamoyltransferase (EC. 2.1.3.2.) 
was assayed by a modification of the calorimetric 
method described by Gerhart and Pardee [ 111. 
Except when otherwise indicated, the incubation 
mixture contained: 0.02 ml T&-Cl pH 9.5,0.07 ml 
0.1 M potassium aspartate pH 7.0,0.36 ml enzyme 
solution, and 0.05 ml dilithium carbamoyl phosphate 
(8 mg/ml) the addition of which started the reaction. 
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The assay was carried out for 30 min at 30°C and 
stopped by transfer of 0.15 ml incubation mixture 
to 1 .O ml acid monoxime reagent [ 111, 
One unit of activity is defined as the amount of 
enzyme which produces 1 nmole of carbamoyl 
aspartate per min. Protein concentrations were 
determined according to Lowry et al. [12] using 
bovine serum albumin as standard. 
2.4. Purification procedures 
All operations were carried out at 0-4°C. 
2.4.1. The wild type enzyme 
A summary of the purification is given in table 1. 
Approx. 400 ml of crude extract was first subjected 
to streptomycin sulfate treatment. 10% streptomycin 
sulfate was added to a final concentration of 1%. 
After centrifugation the precipitate was discarded, 
and solid ammonium sulfate was added to the super- 
natant. Precipitation was allowed to occur for two 
hours. The enzymatic activity was found in the 
precipitate between 40 and 60% saturation, which 
was collected by centrifugation at 12 000 g for 
10 min, and kept for further purification steps. 
The pellet was dissolved in minimal amount of 
homogenizing buffer and applied to a Sephadex 
G-200 column (2.5 X 93 cm), equilibrated and 
eluted with homogenizing buffer without PTU. The 
active fractions were pooled and concentrated by 
ammonium sulfate precipitation (70% saturation), 
and the gel filtration was repeated. The pooled active 
fractions were applied to a DEAE-Sephadex A-50 
column (2.5 X 27 cm) equilibrated with 0.01 M 
potassium phosphate pH 8.2, 10% in glycerol and 
1 mM in mercaptoethanol and EDTA. Elution was 
carried out with the same buffer utilizing a KCl 
gradient from 0 to 200 mM. The hardly retarded 
enzyme was concentrated as above, and was then 
found to be stable for at least 14 days when kept 
at 0-4°C. 
B. The ra 9 k enzyme 
ACT from the rudimentary strain was partially 
purified by streptomycin sulfate and ammonium 
sulfate precipitation as described above, with the 
noticeable exception that this enzyme precipitated 
below 40% saturation with ammonium sulfate. 
2.5. Molecular weight determination 
The mol. wts of the enzymes were estimated by 
gel filtration on Sephadex G-200 using the following 
marker proteins, with molecular weights in parentheses. 
P_galactosidase (5 15 000), ACT from E. coli (3 10 000), 
purine nucleoside phosphorylase (140 000), bovine 
serum albumin (68 000) and cytochrome c (12 400). 
The column (1.5 X 90 cm) was equilibrated and 
eluted with the homogenizing buffer without PTU 
as above. 
Table 1 
Purification scheme for wild type ACT 
Source Activity Total act. Spec. act. Yield Fold 
units/ml units units/mg prot. % purified 
Crude extract 
Streptomycin 
supernatant 
Ammonium sulfate 
precip., dissolved 
1st G-200 eluate, 
concentrated 
8.1 2200 0.74 100 1.0 
7.0 2200 0.59 100 0.8 
17.1 358 0.82 16.3 1.1 
48.6 165 3.22 7.5 4.4 
2nd G200 eluate, 
concentrated 
18.5 37 4.48 1.7 6.1 
DEAE A-50 eluate, 
concentrated 
35.5 7 35.50 0.3 48.0 
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2.6. Kinetics of the wild type enzyme 
The apparent K, values for the substrates potassium 
aspartate and carbamoyl phosphate were determined 
on purified enzyme and for aspartate on crude extract 
as well. Furthermore, the possible effect of 2 X 10e4 M 
ATP, UTP or CTP on the activity of the purified enzyme 
was investigated within a range of O-20 mM potassium 
aspartate. 
2.1. Chemicals 
Sephadex G-200 and DEAE-Sephadex A-50 from 
Pharmacia Fine Chemicals. Bovine serum albumin, 
cytochrome c, carbamoyl phosphate, carbamoyl 
aspartate, CTP, streptomycin sulfate, and Tris from 
Sigma Chemical Company. ATP, UTP and /?-galacto- 
sidase from Boehringer. All other chemicals from 
Merck. Purine nucleoside phosphorylase was a gift 
from Dr Per Nygaard. E. coli ACT was prepared 
according to Gerhart and Holoubek [ 131. 
3. Results 
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Fig.1. Mol. wt estimates of aspartate carbamoyltransferase 
(ACT) from wild type (w.t.) Drosophila melanogaster and 
from the rudimentary mutant strain ?a9 k by gel fiitration 
on Sephadex C-200. Marker proteins used were: @-galact* 
sidase, ACT, and purine nucleoside phosphorylase from E. 
coli, bovine serum albumin, and cytochrome c from horse 
heart. K, = ( Ve- V,)/( Vt- Vo). (Sephadex@ gel filtration 
Purification of the wild type enzyme resulted in 
a 48-fold increase in specific activity relative to that 
of the crude larval extract (table 1). The enzyme was 
found to have a mol. wt of about 390 000, whereas 
the ACT from the mutant strain had an elution 
profile from the Sephadex G-200 column correspond- 
ing to a protein with a molecular weight of only about 
175 000 (fig. 1). A difference between the two enzymes 
was also found in their behaviour towards ammonium 
sulfate precipitation, where the r39 k enzyme preci- 
pitated below 40% saturation, whereas wild type ACT 
was recovered in the fraction that precipitated between 
40 and 60% saturation. 
Kinetic investigations demonstrated that wild type 
ACT is subject to substrate inhibition at aspartate 
concentrations above 14 mM (fig.2). The apparent 
Kn, values for aspartate and carbamoyl phosphate 
were estimated to be 5.4 X 10e3 M and 4.4 X 10e4 M 
respectively (figs. 2 and 3). 
The nucleotides ATP, UTP and CTP were tested 
for their possible activating and inhibitory influence 
on the activity of wild type ACT. Neither was found 
to have any effect at the concentrations used. 
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Fig.2. Aspartate saturation curve for wild type Drosophila 
ACT. The reaction mixture (0.500 ml) contained 20 nmol 
Tris-Cl pH 9.5, 2 nmol dilithium carbamoyl phosphate, 
0.200 ml crude extract and the indicated concentsations 
of L-aspartate. Insert: Lmeweaver-Burk plot of the data. 
V = units per ml enzyme. 
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Fig.3. Carbamoyl phosphate saturation curve for wild type 
Drosophila ACT. The reaction mixture (0.500 ml) contained 
20 firno Tris-Cl pH 9.5, 7 Nmol potassium aspartate pH 7.0, 
0.025 ml purified enzyme and the indicated concentrations 
of carbamoyl phosphate. Insert: Lineweaver-Burk plot of 
the data. Y = units per ml enzyme. 
4. Discussion 
The findings that rudimentary mutants of D. 
melanogaster have a nutritional requirement for 
pyrimidines that can be satisfied by the early inter- 
mediate carbamoyl aspartate [2], and that some 
rudimentary strains are deficient in ACT while others 
are not 131, suggested that the r locus determines 
the activities of the two first enzymes in pyrimidine 
biosynthesis, CPS and ACT, [3], the latter being 
coded for by the proximal part of the locus [4]. 
This has recently been confirmed [6] and extended 
to include the third enzyme in the pathway, DHO 
[91. 
The complex pattern of complementation within 
the r locus [ 14- 161 indicates that the wild type 
locus determines a multimeric protein [ 14- 161, 
possibly an enzyme complex [ 141, and it has there- 
fore been suggested, as an extension of the above 
hypothesis, that CPS and ACT in D. melanogaster 
form a bifunctional enzyme complex [4,7]. In that 
case the situation will be similar to the one found in 
yeast and Neurospora, the two eukaryotes in which 
the genetic regulation of pyrimidine biosynthesis has 
so far been studied in greatest detail [8]. Also in 
mammals, where the genetics of the system is unknown, 
has ACT been found to exist in a high molecular 
weight complex, possibly including both CPS 
and DHO [&lo]. 
In the present study wild type ACT from 
Drosophila has been found to have a molecular weight 
of about 390 000. Although much smaller than the 
CPS-ACT complexes found in yeast (800 000) [ 171 
and Neurospora (650 000) [ 181, this does suggest 
a multimeric protein big enough to accomodate two 
enzymes. In fact, in the absence of UTP the enzyme 
aggregate from yeast dissociates into ‘half-molecules’ 
of mol. wt 380 000, which retain both CPS and ACT 
activities [ 171. In preparations from Neurospora a 
CPS-ACT complex of similar size, as determined by 
sucrose gradient centrifugation, has also been 
observed, but only in the presence of UTP [ 181. 
The hypothesis that ACT in wild type Drosophila 
is part of a CPS-ACT complex has been strengthened 
through the observation reported here, that ACT from 
the r3gk strain has a mol. wt of only about 175 000. 
This mutant has wild type levels of ACT and is 
probably deficient in CPS [3,6]. The simplest expla- 
nation for the observed differences in molecular sizes 
of ACT is, therefore, that in the r3gk mutants the 
CPS moiety of the complex is lacking, either because 
it is not formed at all, or because it, although present 
in the cells, is changed in such a way that it is no 
longer able to form a complex with ACT. The latter 
property may be essential for the function of the 
pathway and thereby for the complementation 
properties of various alleles, regardless of the enzyme 
activity patterns measured in vitro. 
It is thus suggested that the 175 000 mol. wt 
ACT of the r3gk mutant represents the ACT subunit 
in the 390 000 mol. wt wild type complex. The 
possibility that this complex is only a part of the 
functional in vivo complex, and that it may include 
DHO [9], has to be left open at the moment. 
According to the proposed model, the 175 000 
mol. wt ACT corresponds to the 138 000 mol. wt 
ACT subunit in yeast, which in itself is probably a 
hexamer of a single polypeptide chain of a mol. wt 
of about 21 000 [ 191. The Drosophila ACT molecule 
is most probably also a multimeric protein. In fact, 
preliminary experiments, involving precipitation of 
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the wild type enzyme with 1.6 potassium phosphate 
instead of 60% ammonium sulfate, have produced 
an enzymatically active ACT with a mol. wt of only 
about 68 000 [20]. 
Since the discovery in E. coli of the regulatory 
function of ACT in pyrimidine biosynthesis [ 11,2 1 ] , 
the kinetic properties of this enzyme from various 
other sources have been extensively investigated 
[8,22]. Substrate inhibition by aspartate, as reported 
for Drosophila ACT in this paper, has also been found 
for bacterial [23,24], plant [25], and mammalian 
ACT [ 10,261. 
In vivo regulation of the enzymatic activity 
through feedback inhibition exerted by pyrimidine 
nucleotides has been suggested for ACT from 
bacteria [11,21,28], yeast [29], and higher plants 
[25,30,31]. Some bacterial enzymes, like the so- 
called C-class ACT from B. subtilis, are not inhibited 
by nucleotides [28], neither is ACT from Neurospora 
[32] and mammalian tissues [8]. Before the nature 
of the in vivo complex has been established it is 
impossible to draw any conclusions from in vitro 
effector studies about a regulatory function of 
Drosophila ACT. Thus, ACT from yeast is strongly 
inhibited by UTP when part of the 800 000 mol. 
wt complex, but only poorly so in the ‘half-molecule’ 
of 380 000 mol. wt [17]. 
The various patterns of regulation of pyrimidine 
biosynthesis in different organisms reflect the meta- 
bolic complexity caused by the dual role of carbamoyl 
phosphate as precursor for pyrimidines as well as for 
arginine (urea) [8,22,33]. Pyrimidine-mediated 
repression of enzyme synthesis does probably not 
take place in Drosophila [3]. As for regulation on the 
enzyme (complex) level, the Drosophila system is of 
particular interest, also from an evolutionary point 
of view, since insects apparently do not have 
(retained?) the ability to synthesize arginine [34,35,36] 
If feedback inhibition is involved in the regulation of 
pyrimidine biosynthesis in Drosophila, it seems likely 
that the target will be the first enzyme in the path- 
way, i.e. carbamoyl phosphate synthetase. 
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